Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05710172 · ClinicalTrials.gov registry record · NA

Evaluation of Auditory Mirror-therapy for Tinnitus

A NA study of Tinnitus, sponsored by Spaulding Rehabilitation Hospital.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05710172 is a NA study of Tinnitus that is active but no longer recruiting, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 50 participants, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05710172, a NA study of Tinnitus, is active but no longer recruiting, sponsored by Spaulding Rehabilitation Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The investigators will evaluate the effects of wearing auditory mirror earmuffs on tinnitus and on audiometry.The auditory mirror earmuffs is a device that re-routes auditory input from the left side of the head to the right ear, and vice verse, thereby flipping the auditory input. This procedure is called Auditory Mirror Therapy (AMT).

Conditions Studied

Interventions

  • DEVICE Auditory Mirror Therapy

Study Locations (1)

Massachusetts

  • Spaulding Rehabilitation Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-10-04
Est. Completion 2025-11-30
Phase NA

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT05710172

The ClinicalTrials.gov registry entry for NCT05710172 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 1 intervention - of which Auditory Mirror Therapy is the first listed.

NCT05710172 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05710172 about?

NCT05710172 is a clinical study titled "Evaluation of Auditory Mirror-therapy for Tinnitus". The investigators will evaluate the effects of wearing auditory mirror earmuffs on tinnitus and on audiometry.The auditory mirror earmuffs is a device that re-routes auditory input from the left side of the head to the right ear, and vice verse, thereby flipping the auditory input. This procedure is...

What is the current status of trial NCT05710172?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-10-04. Estimated completion is 2025-11-30.

What conditions does trial NCT05710172 study?

This clinical trial studies the following conditions: Tinnitus.

What interventions are being tested in trial NCT05710172?

The interventions under investigation include: Auditory Mirror Therapy (DEVICE).

Who is sponsoring clinical trial NCT05710172?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05710172 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tinnitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.